Clinical Trial Update: Safety and Efficacy of Xenical in Children and Adolescents With Obesity-Related Diseases [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety and efficacy of Xenical (orlistat) in children and adolescents with obesity-related diseases; results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Hypertension
• Metabolic Syndrome
• Obesity
• Obstructive Sleep Apnea

Drugs mentioned

• XENICAL (orlistat)

Snippet

Sponsor: Jack Yanovski | Conditions: Diabetes Mellitus, Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2012-12-18